Literature DB >> 20672311

The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.

Stefan J Teipel1, Thomas Meindl, Lea Grinberg, Michel Grothe, Jose L Cantero, Maximilian F Reiser, Hans-Jürgen Möller, Helmut Heinsen, Harald Hampel.   

Abstract

Few studies have investigated in vivo changes of the cholinergic basal forebrain in Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI), an at risk stage of AD. Even less is known about alterations of cortical projecting fiber tracts associated with basal forebrain atrophy. In this study, we determined regional atrophy within the basal forebrain in 21 patients with AD and 16 subjects with MCI compared to 20 healthy elderly subjects using deformation-based morphometry of MRI scans. We assessed effects of basal forebrain atrophy on fiber tracts derived from high-resolution diffusion tensor imaging (DTI) using tract-based spatial statistics. We localized significant effects relative to a map of cholinergic nuclei in MRI standard space as determined from a postmortem brain. Patients with AD and MCI subjects showed reduced volumes in basal forebrain areas corresponding to anterior medial and lateral, intermediate and posterior nuclei of the Nucleus basalis of Meynert (NbM) as well as in the diagonal band of Broca nuclei (P < 0.01). Effects in MCI subjects were spatially more restricted than in AD, but occurred at similar locations. The volume of the right antero-lateral NbM nucleus was correlated with intracortical projecting fiber tract integrity such as the corpus callosum, cingulate, and the superior longitudinal, inferior longitudinal, inferior fronto-occipital, and uncinate fasciculus (P < 0.05, corrected for multiple comparisons). Our findings suggest that a multimodal MRI-DTI approach is supportive to determine atrophy of cholinergic nuclei and its effect on intracortical projecting fiber tracts in AD.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20672311      PMCID: PMC5899896          DOI: 10.1002/hbm.21111

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  70 in total

1.  Nonrigid registration using free-form deformations: application to breast MR images.

Authors:  D Rueckert; L I Sonoda; C Hayes; D L Hill; M O Leach; D J Hawkes
Journal:  IEEE Trans Med Imaging       Date:  1999-08       Impact factor: 10.048

Review 2.  Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review.

Authors:  Yaniv Assaf; Ofer Pasternak
Journal:  J Mol Neurosci       Date:  2008       Impact factor: 3.444

3.  Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region.

Authors:  Kathrin Muth; Ralf Schönmeyer; Silke Matura; Corinna Haenschel; Johannes Schröder; Johannes Pantel
Journal:  Biol Psychiatry       Date:  2009-04-17       Impact factor: 13.382

4.  Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.

Authors:  P Fischer; S Jungwirth; S Zehetmayer; S Weissgram; S Hoenigschnabl; E Gelpi; W Krampla; K H Tragl
Journal:  Neurology       Date:  2007-01-23       Impact factor: 9.910

5.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

6.  Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease.

Authors:  M Berres; A U Monsch; F Bernasconi; B Thalmann; H B Stähelin
Journal:  Stud Health Technol Inform       Date:  2000

7.  Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker; Corinne Dulberg; Robert A Sweet; H Michael Gach; Steven T Dekosky
Journal:  Arch Neurol       Date:  2007-03

8.  Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.

Authors:  Stefan J Teipel; Christine Born; Michael Ewers; Arun L W Bokde; Maximilian F Reiser; Hans-Jürgen Möller; Harald Hampel
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

9.  Hypertrophy of cholinergic neurones of the rat basal nucleus following section of the corpus callosum.

Authors:  R C Pearson; M V Sofroniew; T P Powell
Journal:  Brain Res       Date:  1985-07-15       Impact factor: 3.252

10.  Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.

Authors:  Rachael I Scahill; Jonathan M Schott; John M Stevens; Martin N Rossor; Nick C Fox
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

View more
  53 in total

Review 1.  Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.

Authors:  Panos Theofilas; Sara Dunlop; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

3.  Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan J Teipel
Journal:  Biol Psychiatry       Date:  2011-08-04       Impact factor: 13.382

Review 4.  Staging Alzheimer's disease progression with multimodality neuroimaging.

Authors:  Michael Ewers; Giovanni B Frisoni; Stefan J Teipel; Lea T Grinberg; Edson Amaro; Helmut Heinsen; Paul M Thompson; Harald Hampel
Journal:  Prog Neurobiol       Date:  2011-06-22       Impact factor: 11.685

5.  Destruction of white matter integrity in patients with mild cognitive impairment and Alzheimer disease.

Authors:  Xiaoyan Sun; David Salat; Kristen Upchurch; Rebecca Deason; Neil Kowall; Andrew Budson
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

6.  Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study.

Authors:  Ingo Kilimann; Michel Grothe; Helmut Heinsen; Eduardo Joaquim Lopez Alho; Lea Grinberg; Edson Amaro; Gláucia Aparecida Bento Dos Santos; Rafael Emídio da Silva; Alex J Mitchell; Giovanni B Frisoni; Arun L W Bokde; Andreas Fellgiebel; Massimo Filippi; Harald Hampel; Stefan Klöppel; Stefan J Teipel
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.

Authors:  Giselli Scaini; Tássia Tonon; Carolina F Moura de Souza; Patricia F Schuk; Gustavo C Ferreira; Joao Seda Neto; Tatiana Amorin; Ida Vanessa D Schwartz; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

8.  Cholinergic neurons excite cortically projecting basal forebrain GABAergic neurons.

Authors:  Chun Yang; James T McKenna; Janneke C Zant; Stuart Winston; Radhika Basheer; Ritchie E Brown
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

9.  Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan Teipel
Journal:  Neurobiol Aging       Date:  2012-11-15       Impact factor: 4.673

Review 10.  Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.

Authors:  Elizabeth C Ballinger; Mala Ananth; David A Talmage; Lorna W Role
Journal:  Neuron       Date:  2016-09-21       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.